Cells are [still] black boxes
Most of the details of how their fundamental components – proteins – interact, co-localize and traffick together to manifest complex functional responses remain hidden from view. Our mission is to generate the first complete cellular proteome maps with unprecedented detail to reveal disease mechanisms and find new drug targets.
Until now
Prisma is building the new era of high definition spatial proteomics
Our Technology
Unveiling the Cellular Proteome: A New Era of Biomedical Research
Imagine a world where we can map every protein within a cell, revealing its location and function in stunning detail. This is the future Prisma is building with in situ proteomics, a revolutionary approach that analyzes proteins directly in their native environment.
This video dives into the core concepts behind Prisma's groundbreaking technology. Our innovative platform leverages the power of our OMNI Probe, a novel reagent that binds directly to the n-terminal amino acid of proteins and generates unique fluorescent signatures based on the amino acid side chain and post-translational modifications. Combined with our cutting-edge, light-based sequencing technique, Prisma's platform enables proteome-scale analysis of proteins, whether they reside on a surface or within the intricate world of a cell.
Contact us to find out more information and how we can work together and tackle the final frontier of human biology
Our Team
Dr. Andrew Emili, PhD
Co-Founder
Chief Executive Officer
Dr. Aaron Beeler, PhD
Co-Founder
CSO and Head of Chemistry
Dr. Anderson Chen, PhD
Co-Founder
Chief Imaging Technologies Officer
Dr. Jacob LaPorte, PhD
Co-Founder
Chief Business Officer
Dr. Andrew Martin
Scientist I
Dr. Eashita Das
Scientist I
Carl White
Data Scientist
Mitchell Clough
Scientist I
Andrew Chan
Associate Scientist
Landon Kushimi
Associate Data Analyst
Advisors
Dr. Xiaolin Nan, PhD
Knight Cancer Institute, OHSU
Super Resolution Microscopy Expert
Dr. Brigitte Ritter, PhD
Boston University
Cell Biology and Assays Expert
Dr. Mark Crovella, PhD.
Boston Universtiy
Data and Network Sciences Thought Leader
Dr. Amanda Cashin, PhD
Former Global Head & Co-Founder of Illumina Accelerator & Illumina for Startups
investors
Dr. Carlo Rizzuto, PhD
Versant Ventures
Managing Director
Dr. Alex Mayweg, PhD
Versant Ventures
Managing Director